/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

D

Duygu Tosun

Ministry of Health(TR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

235

Papers

8.5K

Citations

51

h-index

121

i10-index

Duygu Tosun is an academic researcher from Ministry of Health. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & Functional Brain Connectivity Studies & Alzheimer's disease research and treatments. The author has an h-index of 51, co-authored 200 publications.

ORCID: 0000-0001-8644-7724

Research Topics

Dementia and Cognitive Impairment Research Functional Brain Connectivity Studies Alzheimer's disease research and treatments Advanced Neuroimaging Techniques and Applications Parkinson's Disease Mechanisms and Treatments

Papers by this author

works

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

2018 · Annals of Clinical and Translational Neurology · 633 citations

https://doi.org/10.1002/acn3.644

Kenneth Marek Sohini Chowdhury Andrew Siderowf Shirley Lasch

Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer’s Disease

2015 · Cell Reports · 218 citations

https://doi.org/10.1016/j.celrep.2014.12.034

Ashish Raj Eve LoCastro Amy Kuceyeski Duygu Tosun

Locally linear embedding (LLE) for MRI based Alzheimer's disease classification

2013 · NeuroImage · 163 citations

https://doi.org/10.1016/j.neuroimage.2013.06.033

Xin Liu Duygu Tosun Michael W. Weiner Norbert Schuff

Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression

2022 · JAMA Psychiatry · 139 citations

https://doi.org/10.1001/jamapsychiatry.2022.0020

Junhao Wen Cynthia H.Y. Fu Duygu Tosun Yogasudha Veturi

Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

2019 · The Lancet Neurology · 135 citations

https://doi.org/10.1016/s1474-4422(19)30319-9

Tanya Simuni Liz Uribe Hyunkeun Ryan Cho Chelsea Caspell-Garcia

Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study

2020 · Movement Disorders · 78 citations

https://doi.org/10.1002/mds.27989

Tanya Simuni Michael C. Brumm Liz Uribe Chelsea Caspell‐Garcia

Research topics

topics

Dementia and Cognitive Impairment Research

Functional Brain Connectivity Studies

Alzheimer's disease research and treatments

Advanced Neuroimaging Techniques and Applications

Parkinson's Disease Mechanisms and Treatments

Chat about Author

Papers

Chat

Click to start Chat